How dosing might influence the conclusion in an antipsychotic polypharmacy effectiveness trial

Am J Psychiatry. 2011 Oct;168(10):1117; author reply 1117. doi: 10.1176/appi.ajp.2011.11050751.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Female
  • Humans
  • Male
  • Polypharmacy*
  • Schizophrenia / drug therapy*

Substances

  • Antipsychotic Agents